299 related articles for article (PubMed ID: 23295559)
1. Burden of bloodstream infection caused by extended-spectrum β-lactamase-producing enterobacteriaceae determined using multistate modeling at a Swiss University Hospital and a nationwide predictive model.
Stewardson A; Fankhauser C; De Angelis G; Rohner P; Safran E; Schrenzel J; Pittet D; Harbarth S
Infect Control Hosp Epidemiol; 2013 Feb; 34(2):133-43. PubMed ID: 23295559
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and Burden of Bloodstream Infections Caused by Extended-Spectrum Beta-Lactamase Producing Enterobacteriaceae in a Pediatric Hospital in Senegal.
Ndir A; Diop A; Faye PM; Cissé MF; Ndoye B; Astagneau P
PLoS One; 2016; 11(2):e0143729. PubMed ID: 26867226
[TBL] [Abstract][Full Text] [Related]
3. [Impact of extended-spectrum β-lactamase on clinical outcome and medical cost in patients with bloodstream infection due to Klebsiella pneumoniae].
Li JQ; Tang CQ; Wang H; Ji SZ; Lü KY; Xiao SC; Deng AM; Huang Y; Xia ZF
Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1903-6. PubMed ID: 27373357
[TBL] [Abstract][Full Text] [Related]
4. The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.
Stewardson AJ; Allignol A; Beyersmann J; Graves N; Schumacher M; Meyer R; Tacconelli E; De Angelis G; Farina C; Pezzoli F; Bertrand X; Gbaguidi-Haore H; Edgeworth J; Tosas O; Martinez JA; Ayala-Blanco MP; Pan A; Zoncada A; Marwick CA; Nathwani D; Seifert H; Hos N; Hagel S; Pletz M; Harbarth S;
Euro Surveill; 2016 Aug; 21(33):. PubMed ID: 27562950
[TBL] [Abstract][Full Text] [Related]
5. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Tumbarello M; Sanguinetti M; Montuori E; Trecarichi EM; Posteraro B; Fiori B; Citton R; D'Inzeo T; Fadda G; Cauda R; Spanu T
Antimicrob Agents Chemother; 2007 Jun; 51(6):1987-94. PubMed ID: 17387156
[TBL] [Abstract][Full Text] [Related]
6. Bloodstream infection due to extended-spectrum beta-lactamase (ESBL)-positive K. pneumoniae and E. coli: an analysis of the disease burden in a large cohort.
Leistner R; Gürntke S; Sakellariou C; Denkel LA; Bloch A; Gastmeier P; Schwab F
Infection; 2014 Dec; 42(6):991-7. PubMed ID: 25100555
[TBL] [Abstract][Full Text] [Related]
7. Burden of meticillin-resistant Staphylococcus aureus infections at a Swiss University hospital: excess length of stay and costs.
Macedo-Viñas M; De Angelis G; Rohner P; Safran E; Stewardson A; Fankhauser C; Schrenzel J; Pittet D; Harbarth S
J Hosp Infect; 2013 Jun; 84(2):132-7. PubMed ID: 23608003
[TBL] [Abstract][Full Text] [Related]
8. Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
Augustine MR; Testerman TL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
Infect Control Hosp Epidemiol; 2017 Mar; 38(3):266-272. PubMed ID: 27989244
[TBL] [Abstract][Full Text] [Related]
9. Bloodstream infection with extended-spectrum beta-lactamase-producing Enterobacteriaceae at a tertiary care hospital in New Zealand: risk factors and outcomes.
Freeman JT; McBride SJ; Nisbet MS; Gamble GD; Williamson DA; Taylor SL; Holland DJ
Int J Infect Dis; 2012 May; 16(5):e371-4. PubMed ID: 22401750
[TBL] [Abstract][Full Text] [Related]
10. Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?
Barbier F; Pommier C; Essaied W; Garrouste-Orgeas M; Schwebel C; Ruckly S; Dumenil AS; Lemiale V; Mourvillier B; Clec'h C; Darmon M; Laurent V; Marcotte G; Lucet JC; Souweine B; Zahar JR; Timsit JF;
J Antimicrob Chemother; 2016 Apr; 71(4):1088-97. PubMed ID: 26755492
[TBL] [Abstract][Full Text] [Related]
11. Clinical and economic impact of bacteremia with extended- spectrum-beta-lactamase-producing Enterobacteriaceae.
Schwaber MJ; Navon-Venezia S; Kaye KS; Ben-Ami R; Schwartz D; Carmeli Y
Antimicrob Agents Chemother; 2006 Apr; 50(4):1257-62. PubMed ID: 16569837
[TBL] [Abstract][Full Text] [Related]
12. Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
Birgand G; Armand-Lefevre L; Lolom I; Ruppe E; Andremont A; Lucet JC
Am J Infect Control; 2013 May; 41(5):443-7. PubMed ID: 22998785
[TBL] [Abstract][Full Text] [Related]
13. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacter cloacae bloodstream infections.
Qureshi ZA; Paterson DL; Pakstis DL; Adams-Haduch JM; Sandkovsky G; Sordillo E; Polsky B; Peleg AY; Bhussar MK; Doi Y
Int J Antimicrob Agents; 2011 Jan; 37(1):26-32. PubMed ID: 21075605
[TBL] [Abstract][Full Text] [Related]
14. Assessment of the clinical significance of production of extended-spectrum beta-lactamases (ESBL) by Enterobacteriaceae.
Henshke-Bar-Meir R; Yinnon AM; Rudensky B; Attias D; Schlesinger Y; Raveh D
Infection; 2006 Apr; 34(2):66-74. PubMed ID: 16703295
[TBL] [Abstract][Full Text] [Related]
15. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies.
Vehreschild MJ; Hamprecht A; Peterson L; Schubert S; Häntschel M; Peter S; Schafhausen P; Rohde H; Lilienfeld-Toal MV; Bekeredjian-Ding I; Libam J; Hellmich M; Vehreschild JJ; Cornely OA; Seifert H
J Antimicrob Chemother; 2014 Dec; 69(12):3387-92. PubMed ID: 25103492
[TBL] [Abstract][Full Text] [Related]
16. Variation of effect estimates in the analysis of mortality and length of hospital stay in patients with infections caused by bacteria-producing extended-spectrum beta-lactamases: a systematic review and meta-analysis.
Shamsrizi P; Gladstone BP; Carrara E; Luise D; Cona A; Bovo C; Tacconelli E
BMJ Open; 2020 Jan; 10(1):e030266. PubMed ID: 31964661
[TBL] [Abstract][Full Text] [Related]
17. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs.
Orsi GB; Di Stefano L; Noah N
Infect Control Hosp Epidemiol; 2002 Apr; 23(4):190-7. PubMed ID: 12002233
[TBL] [Abstract][Full Text] [Related]
18. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis.
Muro S; Garza-González E; Camacho-Ortiz A; González GM; Llaca-Díaz JM; Bosques F; Rositas F
Chemotherapy; 2012; 58(3):217-24. PubMed ID: 22814216
[TBL] [Abstract][Full Text] [Related]
19. Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.
Trecarichi EM; Cauda R; Tumbarello M
Future Microbiol; 2012 Oct; 7(10):1173-89. PubMed ID: 23030423
[TBL] [Abstract][Full Text] [Related]
20. Burden of antimicrobial resistance in European hospitals: excess mortality and length of hospital stay associated with bloodstream infections due to Escherichia coli resistant to third-generation cephalosporins.
de Kraker ME; Wolkewitz M; Davey PG; Koller W; Berger J; Nagler J; Icket C; Kalenic S; Horvatic J; Seifert H; Kaasch A; Paniara O; Argyropoulou A; Bompola M; Smyth E; Skally M; Raglio A; Dumpis U; Melbarde Kelmere A; Borg M; Xuereb D; Ghita MC; Noble M; Kolman J; Grabljevec S; Turner D; Lansbury L; Grundmann H
J Antimicrob Chemother; 2011 Feb; 66(2):398-407. PubMed ID: 21106563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
